Open-label Safety Study in Adults With ADHD

NCT02160262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

724

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Dasotraline

Sponsor

Sumitomo Pharma America, Inc.